Why Neogenomics Inc. (NASDAQ:NEO) Stock declined -27.18% in Last Three Months?

BTIG Research lowered the price target for the Neogenomics Inc. (NASDAQ:NEO) stock to “a Buy”. The rating was released on December 29, 2023, according to finviz. The stock was upgraded by BTIG Research, who disclosed in a research note on May 09, 2023, from Neutral to Buy and set the price objective to $25. In […]

Don’t be afraid of Neogenomics Inc. (NEO) Stock despite uncertainty and doubt

BTIG Research lowered the price target for the Neogenomics Inc. (NASDAQ:NEO) stock to “a Buy”. The rating was released on December 29, 2023, according to finviz. The stock was upgraded by BTIG Research, who disclosed in a research note on May 09, 2023, from Neutral to Buy and set the price objective to $25. In […]

Growing at an Unbelievable Rate: Neogenomics Inc. (NEO) Stock

BTIG Research lowered the price target for the Neogenomics Inc. (NASDAQ:NEO) stock to “a Buy”. The rating was released on December 29, 2023, according to finviz. The stock was upgraded by BTIG Research, who disclosed in a research note on May 09, 2023, from Neutral to Buy and set the price objective to $25. In […]

The growth of Neogenomics Inc. (NEO) Stock is expected to continue

BTIG Research lowered the price target for the Neogenomics Inc. (NASDAQ:NEO) stock to “a Buy”. The rating was released on December 29, 2023, according to finviz. The stock was upgraded by BTIG Research, who disclosed in a research note on May 09, 2023, from Neutral to Buy and set the price objective to $25. In […]

Is Neogenomics Inc. (NEO) Stock a good investment?

BTIG Research lowered the price target for the Neogenomics Inc. (NASDAQ:NEO) stock to “a Buy”. The rating was released on December 29, 2023, according to finviz. The stock was upgraded by BTIG Research, who disclosed in a research note on May 09, 2023, from Neutral to Buy and set the price objective to $25. In […]

The future of Neogenomics Inc. (NEO) Stock is still in tatters?

BTIG Research lowered the price target for the Neogenomics Inc. (NASDAQ:NEO) stock to “a Buy”. The rating was released on December 29, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock price […]

Growing at an Unbelievable Rate: Neogenomics Inc. (NEO) Stock

BTIG Research lowered the price target for the Neogenomics Inc. (NASDAQ:NEO) stock to “a Buy”. The rating was released on December 29, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock price […]